View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Allergy/Asthma News

SPONSORED CONTENT
Save
SPONSORED CONTENT
March 18, 2024
3 min read
Save

Vaccination delayed, avoided with dupilumab treatment

Vaccination delayed, avoided with dupilumab treatment

WASHINGTON — Children taking dupilumab for atopic diseases received measles, mumps and rubella and varicella immunizations later than other children, according to a poster presented here.

SPONSORED CONTENT
March 15, 2024
3 min read
Save

Asthma researcher wants moms, babies to breathe easier through pregnancy research

Asthma researcher wants moms, babies to breathe easier through pregnancy research

Vanessa Murphy, PhD, started her research career in a lab studying preterm birth, which is where she fell in love with pregnancy research.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
March 14, 2024
3 min read
Save

Rebamipide may treat low-grade inflammation in post-COVID syndrome

Rebamipide may treat low-grade inflammation in post-COVID syndrome

WASHINGTON — Rebamipide has potential as treatment for low-grade inflammation among patients with post-COVID syndrome, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SPONSORED CONTENT
March 14, 2024
2 min read
Save

US, world guidelines differ on when to use omalizumab in treating urticaria

US, world guidelines differ on when to use omalizumab in treating urticaria

WASHINGTON — Urticaria treatment guidelines in the United States include more options than the World Allergy Organization’s guidelines, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SPONSORED CONTENT
March 14, 2024
2 min read
Save

Nemolizumab shows long-term efficacy in treatment of prurigo nodularis, atopic dermatitis

Nemolizumab shows long-term efficacy in treatment of prurigo nodularis, atopic dermatitis

SAN DIEGO — At the American Academy of Dermatology Annual Meeting, Galderma announced new data demonstrating nemolizumab’s long-term efficacy in treating prurigo nodularis and atopic dermatitis, according to a press release.

SPONSORED CONTENT
March 14, 2024
1 min read
Save

Frequency of asthma, food allergy ED visits high in African American children

Frequency of asthma, food allergy ED visits high in African American children

WASHINGTON — Compared with white, Asian and Hispanic children, African American children more frequently visited the ED because of asthma or a food allergy, according to study findings.

SPONSORED CONTENT
March 13, 2024
3 min read
Save

Pet owners with allergy can mitigate environmental exposures to allergens

Pet owners with allergy can mitigate environmental exposures to allergens

WASHINGTON — Patients can keep their furry, four-legged friends and still control their pet allergy symptoms, according to a presentation at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SPONSORED CONTENT
March 13, 2024
3 min read
Save

Omalizumab may benefit children with severe asthma, comorbid food allergy

Omalizumab may benefit children with severe asthma, comorbid food allergy

Children with severe allergic asthma and serum total IgE levels between 1,500 kU/L and 3,300 kU/L as well as food allergy benefitted from omalizumab, according to a study published in Pediatric Allergy and Immunology.

SPONSORED CONTENT
March 13, 2024
3 min read
Save

BLOG: Rollover equity: Linking arms with your private equity partner

BLOG: Rollover equity: Linking arms with your private equity partner

As we discussed in our overview of the private equity, or PE, physician practice model, the buyer in an acquisition is often a PE-sponsored management services organization that purchases the nonclinical aspects of the practice’s business.

SPONSORED CONTENT
March 13, 2024
3 min read
Save

Medium-dose inhaled corticosteroid plus LABA best for pediatric uncontrolled asthma

Medium-dose inhaled corticosteroid plus LABA best for pediatric uncontrolled asthma

A medium inhaled corticosteroid dose plus a long-acting beta agonist was found to be the most beneficial step-up treatment option for children with uncontrolled asthma, according to a meta-analysis published in European Respiratory Journal.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails